UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
1751
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.49M | ﹤0.01% |
16,446
-4,923
| -23% | -$433K |
|
1752
Fiverr
FVRR
$327M
| $1.49M | ﹤0.01% |
42,687
+3,351
| +9% | +$122K |
|
1753
Trustmark
TRMK
$2.75B
| $1.49M | ﹤0.01% |
60,343
-7,166
| -11% | -$212K |
|
1754
ePlus
PLUS
$2.35B
| $1.49M | ﹤0.01% |
30,385
+816
| +3% | +$41.4K |
|
1755
Protagonist Therapeutics
PTGX
$9.71B
| $1.49M | ﹤0.01% |
+64,778
| New | +$1.09M |
|
|
CERE
1756
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.49M | ﹤0.01% |
60,965
+9,649
| +19% | +$283K |
|
1757
Orion
OEC
$389M
| $1.48M | ﹤0.01% |
56,818
-10,843
| -16% | -$245K |
|
1758
Cannae Holdings
CNNE
$644M
| $1.48M | ﹤0.01% |
73,440
-20,153
| -22% | -$446K |
|
1759
ADT
ADT
$5.49B
| $1.47M | ﹤0.01% |
202,708
+13,057
| +7% | +$106K |
|
|
IBTX
1760
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.47M | ﹤0.01% |
31,610
+3,165
| +11% | +$180K |
|
1761
Amphastar Pharmaceuticals
AMPH
$896M
| $1.46M | ﹤0.01% |
39,051
-5,036
| -11% | -$165K |
|
1762
Provident Financial Services
PFS
$3.17B
| $1.46M | ﹤0.01% |
76,150
+2,000
| +3% | +$44.2K |
|
1763
Arbor Realty Trust
ABR
$1,000M
| $1.46M | ﹤0.01% |
+126,960
| New | +$1.76M |
|
|
AKRO
1764
DELISTED
Akero Therapeutics
AKRO
| $1.46M | ﹤0.01% |
38,090
+2,121
| +6% | +$94.6K |
|
1765
Carvana
CVNA
$81.5B
| $1.46M | ﹤0.01% |
743,865
-16,700
| -2% | -$29K |
|
1766
FuelCell Energy
FCEL
$1.59B
| $1.45M | ﹤0.01% |
17,005
+4,538
| +36% | +$447K |
|
1767
Pediatrix Medical
MD
$2.12B
| $1.45M | ﹤0.01% |
+97,496
| New | +$1.48M |
|
1768
Peabody Energy
BTU
$3B
| $1.45M | ﹤0.01% |
56,718
-12,821
| -18% | -$341K |
|
1769
Expro Ltd
XPRO
$2.01B
| $1.45M | ﹤0.01% |
79,027
+3,731
| +5% | +$73.2K |
|
1770
3D Systems Corp
DDD
$611M
| $1.45M | ﹤0.01% |
135,059
+4,446
| +3% | +$45.3K |
|
1771
Moog Inc Class A
MOG.A
$13B
| $1.45M | ﹤0.01% |
14,344
+1,519
| +12% | +$146K |
|
1772
PROG Holdings
PRG
$1.68B
| $1.43M | ﹤0.01% |
60,205
-1,816
| -3% | -$40.8K |
|
1773
OceanFirst Financial
OCFC
$1.87B
| $1.43M | ﹤0.01% |
77,489
+4,461
| +6% | +$98.8K |
|
1774
Stewart Information Services
STC
$2.01B
| $1.43M | ﹤0.01% |
35,481
+2,179
| +7% | +$95.4K |
|
|
OPTU
1775
Optimum Communications Inc
OPTU
$306M
| $1.43M | ﹤0.01% |
418,399
-22,289
| -5% | -$94.7K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.